Understanding the Market | LEPU BIO-B rose over 6% in the afternoon, with excellent Phase I clinical data for MRG006A in treating advanced liver cancerZhitong·Jun 12 at 01:57 AM02157-1.38%
LEPU BIO: Fan Xinyu elected as a supervisor of the supervisory boardZhitong·May 19 at 06:40 AM02157-1.38%
In the first quarter of 2026, the pharmaceutical and biotechnology industry showed signs of recovery, with innovative drugs becoming the core growth engine. The Hong Kong innovative drug ETF from Bosera rose over 2% at the beginning of trading腾讯新闻 - 财经·May 6 at 08:59 PM02157-1.38%01530-93.00%
Lepu Biopharma Exits Biotech Marker Regime After Meeting HKEX Mainboard TestsTip Ranks·May 6 at 07:39 AM02157-1.38%
Guotai Junan Securities: Innovation is Key in the Post-Procurement Era, Focus on Investment Opportunities in Domestic New DrugsZhitong·Apr 27 at 08:23 PM600867-3.51%600276-2.74%
LEPU BIO-B plans to appoint Fan Xinyu as a supervisorZhitong·Apr 27 at 08:49 AM02157-1.38%516820-2.53%
Zhitai Biotechnology rushes to the Hong Kong stock market: treating obesity with a net loss of 190 million, Sequoia Capital, BlueRun Ventures, and Aobo are shareholders雷帝网·Apr 25 at 09:39 PM01873+3.70%02157-1.38%
Huachuang Securities Keeps Their Buy Rating on Lepu Biopharma Co. Ltd. Class H (2157)Tip Ranks·Apr 12 at 01:25 AM02157-1.38%513120-1.17%
Assessing Lepu Biopharma’s Valuation After Earnings Turnaround And Share Price SurgeSimplywall·Apr 5 at 12:43 PM560600+0.00%513120-1.17%
BinHui Biotechnology rushes to the Hong Kong stock market: annual loss of 120 million, LEPU BIO and Yangtze River Pharmaceutical are shareholders雷帝网·Apr 5 at 01:23 AM513120-1.17%516500-2.81%
Hong Kong Stock Market Mid-Review: Hang Seng Index up 1.98%, Hang Seng Tech Index up 1.58%Zhitong·Mar 31 at 11:02 PM02157-1.38%688331-5.44%
Hong Kong Stock Movement Update: The medical technology sector rebounds strongly, BAYZED HEALTH surges 20% to lead the gains!HK Stock Alerts·Mar 31 at 11:00 PM02609-38.00%06636-70.00%
Understanding the Market | Pharmaceutical Stocks Show Strong Performance, Innovative Drugs Gradually Approaching Profitability Turning Point, 2026 AACR Annual Meeting is Coming SoonZhitong·Mar 31 at 10:48 PM09995-57.00%02157-1.38%
